S&P 500   4,240.27 (+0.26%)
DOW   32,992.06 (-0.03%)
QQQ   356.81 (+0.53%)
AAPL   172.20 (-0.12%)
MSFT   316.44 (+0.97%)
META   300.48 (-0.15%)
GOOGL   133.54 (+0.84%)
AMZN   126.27 (+1.24%)
TSLA   249.85 (+1.35%)
NVDA   436.99 (+0.42%)
NIO   8.56 (-0.58%)
BABA   84.54 (+0.00%)
AMD   100.76 (+0.68%)
T   14.70 (-0.54%)
F   11.99 (-0.66%)
MU   67.88 (+0.07%)
CGC   0.69 (+0.40%)
GE   107.52 (-0.22%)
DIS   79.69 (+0.19%)
AMC   7.97 (+1.53%)
PFE   34.06 (+0.47%)
PYPL   58.21 (+1.59%)
NFLX   376.06 (-0.18%)
S&P 500   4,240.27 (+0.26%)
DOW   32,992.06 (-0.03%)
QQQ   356.81 (+0.53%)
AAPL   172.20 (-0.12%)
MSFT   316.44 (+0.97%)
META   300.48 (-0.15%)
GOOGL   133.54 (+0.84%)
AMZN   126.27 (+1.24%)
TSLA   249.85 (+1.35%)
NVDA   436.99 (+0.42%)
NIO   8.56 (-0.58%)
BABA   84.54 (+0.00%)
AMD   100.76 (+0.68%)
T   14.70 (-0.54%)
F   11.99 (-0.66%)
MU   67.88 (+0.07%)
CGC   0.69 (+0.40%)
GE   107.52 (-0.22%)
DIS   79.69 (+0.19%)
AMC   7.97 (+1.53%)
PFE   34.06 (+0.47%)
PYPL   58.21 (+1.59%)
NFLX   376.06 (-0.18%)
S&P 500   4,240.27 (+0.26%)
DOW   32,992.06 (-0.03%)
QQQ   356.81 (+0.53%)
AAPL   172.20 (-0.12%)
MSFT   316.44 (+0.97%)
META   300.48 (-0.15%)
GOOGL   133.54 (+0.84%)
AMZN   126.27 (+1.24%)
TSLA   249.85 (+1.35%)
NVDA   436.99 (+0.42%)
NIO   8.56 (-0.58%)
BABA   84.54 (+0.00%)
AMD   100.76 (+0.68%)
T   14.70 (-0.54%)
F   11.99 (-0.66%)
MU   67.88 (+0.07%)
CGC   0.69 (+0.40%)
GE   107.52 (-0.22%)
DIS   79.69 (+0.19%)
AMC   7.97 (+1.53%)
PFE   34.06 (+0.47%)
PYPL   58.21 (+1.59%)
NFLX   376.06 (-0.18%)
S&P 500   4,240.27 (+0.26%)
DOW   32,992.06 (-0.03%)
QQQ   356.81 (+0.53%)
AAPL   172.20 (-0.12%)
MSFT   316.44 (+0.97%)
META   300.48 (-0.15%)
GOOGL   133.54 (+0.84%)
AMZN   126.27 (+1.24%)
TSLA   249.85 (+1.35%)
NVDA   436.99 (+0.42%)
NIO   8.56 (-0.58%)
BABA   84.54 (+0.00%)
AMD   100.76 (+0.68%)
T   14.70 (-0.54%)
F   11.99 (-0.66%)
MU   67.88 (+0.07%)
CGC   0.69 (+0.40%)
GE   107.52 (-0.22%)
DIS   79.69 (+0.19%)
AMC   7.97 (+1.53%)
PFE   34.06 (+0.47%)
PYPL   58.21 (+1.59%)
NFLX   376.06 (-0.18%)
NASDAQ:AMEH

Apollo Medical (AMEH) Stock Forecast, Price & News

$30.42
-0.19 (-0.62%)
(As of 09:30 AM ET)
Compare
Today's Range
$30.42
$30.42
50-Day Range
$29.94
$39.33
52-Week Range
$26.89
$40.81
Volume
1,092 shs
Average Volume
173,998 shs
Market Capitalization
$1.75 billion
P/E Ratio
27.91
Dividend Yield
N/A
Price Target
$52.00

Apollo Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
70.9% Upside
$52.00 Price Target
Short Interest
Bearish
7.89% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.79mentions of Apollo Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
21.62%
From $1.11 to $1.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Medical Sector

166th out of 965 stocks

Management Consulting Services Industry

8th out of 15 stocks


AMEH stock logo

About Apollo Medical (NASDAQ:AMEH) Stock

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

AMEH Price History

AMEH Stock News Headlines

Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
/C O R R E C T I O N -- Apollo Medical Holdings, Inc./
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
Apollo Medical Hlgs's Earnings Outlook
See More Headlines
Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Company Calendar

Last Earnings
8/07/2023
Today
10/03/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMEH
Employees
1,362
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$52.00
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$44.00
Forecasted Upside/Downside
+70.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$45.17 million
Pretax Margin
7.91%

Debt

Sales & Book Value

Annual Sales
$1.14 billion
Cash Flow
$1.24 per share
Book Value
$9.60 per share

Miscellaneous

Free Float
52,692,000
Market Cap
$1.75 billion
Optionable
Not Optionable
Beta
0.89

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Kenneth T. Sim M.D. (Age 69)
    Exec. Chairman
    Comp: $1.49M
  • Dr. Thomas S. Lam M.D. (Age 74)
    M.P.H., Pres, Co-CEO & Director
    Comp: $1.49M
  • Mr. Brandon SimMr. Brandon Sim (Age 29)
    Co-Chief Exec. Officer
    Comp: $1.73M
  • Mr. Chandan Basho (Age 41)
    Chief Strategy Officer, CFO & Corp. Sec.
    Comp: $581.42k
  • Dr. WaiChow Young M.D. (Age 76)
    Chief Admin. Officer
    Comp: $573.67k
  • Mr. John Vong (Age 50)
    Chief Accounting Officer
  • Dr. Jeremy R. Jackson M.D.
    Chief Quality Officer
  • Mr. Neil Ahuja
    Pres of Provider Solutions
  • Yubin Park
    Chief Analytics Officer
  • Dr. Carlos Palacios M.D.
    Chief Medical Officer for Texas













AMEH Stock - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMEH shares.
View AMEH analyst ratings
or view top-rated stocks.

What is Apollo Medical's stock price forecast for 2023?

2 equities research analysts have issued 1-year price objectives for Apollo Medical's stock. Their AMEH share price forecasts range from $44.00 to $60.00. On average, they anticipate the company's share price to reach $52.00 in the next twelve months. This suggests a possible upside of 70.9% from the stock's current price.
View analysts price targets for AMEH
or view top-rated stocks among Wall Street analysts.

How have AMEH shares performed in 2023?

Apollo Medical's stock was trading at $29.59 on January 1st, 2023. Since then, AMEH shares have increased by 2.8% and is now trading at $30.42.
View the best growth stocks for 2023 here
.

Are investors shorting Apollo Medical?

Apollo Medical saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 2,740,000 shares, a decline of 11.0% from the August 31st total of 3,080,000 shares. Based on an average trading volume of 174,000 shares, the days-to-cover ratio is presently 15.7 days. Currently, 7.9% of the company's shares are short sold.
View Apollo Medical's Short Interest
.

When is Apollo Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AMEH earnings forecast
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its quarterly earnings results on Monday, August, 7th. The company reported $0.28 earnings per share for the quarter, meeting analysts' consensus estimates of $0.28. The company earned $348.21 million during the quarter, compared to the consensus estimate of $341.10 million. Apollo Medical had a trailing twelve-month return on equity of 11.00% and a net margin of 3.95%.

What ETFs hold Apollo Medical's stock?
What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical issued an update on its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of $0.95-$1.20 for the period, compared to the consensus estimate of $1.16. The company issued revenue guidance of $1.30 billion-$1.50 billion, compared to the consensus revenue estimate of $1.38 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

How do I buy shares of Apollo Medical?

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $30.42.

How much money does Apollo Medical make?

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $1.75 billion and generates $1.14 billion in revenue each year. The company earns $45.17 million in net income (profit) each year or $1.09 on an earnings per share basis.

How many employees does Apollo Medical have?

The company employs 1,362 workers across the globe.

Does Apollo Medical have any subsidiaries?
The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..
Read More
How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 282-0288, via email at investors@apollomed.net, or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -